Literature DB >> 1981389

Intrathecal and epidural somatostatin in rats: can antinociception, motor effects and neurotoxicity be separated?

Peter Mollenholt1, Claes Post, Ivar Paulsson, Narinder Rawal.   

Abstract

In the present investigation, the antinociceptive, motor blocking and neurotoxic effects of intrathecal and epidural somatostatin (SST) were assessed in rats implanted with lumbar intrathecal and epidural catheters. The doses studied were 5, 7.5, 10, 12.5 and 15 micrograms intrathecally and 100, 250, 400 and 500 micrograms epidurally. It appears that if the intrathecal doses of SST are kept below 15 micrograms and the epidural doses below 250 micrograms, the prolonged tail-flick latency can be separated from the transient motor blockade. The antinociception appears not to be attributable to neurotoxicity by the histological evidence available.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981389     DOI: 10.1016/0304-3959(90)90033-A

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  4 in total

Review 1.  The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.

Authors:  D P Beltrutti; S Moessinger; G Varrassi
Journal:  Curr Rev Pain       Date:  2000

2.  Involvement of spinal somatostatin receptor SST(2A) in inflammation-induced thermal hyperalgesia: ultrastructural and behavioral studies in rats.

Authors:  Jun Zhao; Jiang-Yuan Hu; Yu-Qiu Zhang; Zhi-Qi Zhao
Journal:  Neurochem Res       Date:  2008-05-02       Impact factor: 3.996

Review 3.  Octreotide in gastrointestinal motility disorders.

Authors:  C Owyang
Journal:  Gut       Date:  1994       Impact factor: 23.059

Review 4.  New drugs in the management of the irritable bowel syndrome.

Authors:  M J Farthing
Journal:  Drugs       Date:  1998-07       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.